PURPOSE To analyze the comparative safety and efficacy of two techniques of corneal neurotization (CN) (direct corneal neurotization [DCN] vs indirect corneal neurotization [ICN] for the treatment of neurotrophic keratopathy (NK). DESIGN Multicenter Interventional Prospective Comparative Case Series. METHODS Setting: ASST Santi Paolo e Carlo University Hospital, Milan; S.Orsola-Malpighi University Hospital, Bologna; Santa Maria alle Scotte University Hospital, Siena. Study Population: Consecutive patients with NK undergoing CN between November 2014 and October 2019; Intervention Procedures: DCN was performed by transferring contralateral supraorbital and supratrochlear nerves; ICN was performed using sural nerve graft. Main Outcome Measures: NK healing; corneal sensitivity; corneal nerve fiber length (CNFL) measured by in vivo confocal microscopy (IVCM); complication rate. RESULTS 26 eyes of 25 patients were included: 16 were treated with DCN and 10 with ICN. After surgery, NK healed in all patients after a mean period of 3.9 months without differences between DCN and ICN. Mean corneal sensitivity improved significantly 1 year after surgery (from 3.07 to 22.11 mm; p<0.001) without differences between the two groups. Corneal sub-basal nerve plexus that was absent before surgery in all patients except 4 become detectable in all cases (mean CNFL 14.67±7.92 mm/mm2 1 year postoperatively). No major complications were recorded in both groups. CONCLUSIONS CN allowed the healing of NK in all patients as well as the improvement of corneal sensitivity in the majority of them thanks to nerve regeneration documented by IVCM. One year postoperatively, DCN and ICN showed comparable outcomes.

Direct Versus Indirect Corneal Neurotization for the Treatment of Neurotrophic Keratopahty: a Multicenter Prospective Comparative Study / P. Fogagnolo, G. Giannaccare, F. Bolognesi, M. Digiuni, L. Tranchina, L. Rossetti, A. Dipinto, F. Allevi, A. Lozza, D. Rabbiosi, S. Mariani, M. Pellegrini, F.E. Cazzola, S. Bagaglia, C. Mazzotta, G. Gabriele, P. Gennaro, G. Badiali, C. Marchetti, E.C. Campos, F. Biglioli. - In: AMERICAN JOURNAL OF OPHTHALMOLOGY. - ISSN 0002-9394. - (2020). [Epub ahead of print]

Direct Versus Indirect Corneal Neurotization for the Treatment of Neurotrophic Keratopahty: a Multicenter Prospective Comparative Study

P. Fogagnolo
Primo
;
L. Rossetti;F. Allevi;F. Biglioli
Ultimo
2020

Abstract

PURPOSE To analyze the comparative safety and efficacy of two techniques of corneal neurotization (CN) (direct corneal neurotization [DCN] vs indirect corneal neurotization [ICN] for the treatment of neurotrophic keratopathy (NK). DESIGN Multicenter Interventional Prospective Comparative Case Series. METHODS Setting: ASST Santi Paolo e Carlo University Hospital, Milan; S.Orsola-Malpighi University Hospital, Bologna; Santa Maria alle Scotte University Hospital, Siena. Study Population: Consecutive patients with NK undergoing CN between November 2014 and October 2019; Intervention Procedures: DCN was performed by transferring contralateral supraorbital and supratrochlear nerves; ICN was performed using sural nerve graft. Main Outcome Measures: NK healing; corneal sensitivity; corneal nerve fiber length (CNFL) measured by in vivo confocal microscopy (IVCM); complication rate. RESULTS 26 eyes of 25 patients were included: 16 were treated with DCN and 10 with ICN. After surgery, NK healed in all patients after a mean period of 3.9 months without differences between DCN and ICN. Mean corneal sensitivity improved significantly 1 year after surgery (from 3.07 to 22.11 mm; p<0.001) without differences between the two groups. Corneal sub-basal nerve plexus that was absent before surgery in all patients except 4 become detectable in all cases (mean CNFL 14.67±7.92 mm/mm2 1 year postoperatively). No major complications were recorded in both groups. CONCLUSIONS CN allowed the healing of NK in all patients as well as the improvement of corneal sensitivity in the majority of them thanks to nerve regeneration documented by IVCM. One year postoperatively, DCN and ICN showed comparable outcomes.
Settore MED/30 - Malattie Apparato Visivo
Settore MED/29 - Chirurgia Maxillofacciale
2020
11-lug-2020
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/752758
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 24
social impact